Table 4 Flash glucose monitoring (FGM) data analysis and symptom events reported.
From: Use of flash glucose monitoring for post-bariatric hypoglycaemia diagnosis and management
Patient A | Patient B | |
|---|---|---|
Events report | ||
LGE (n) | 3 | 12 |
Preceded by IFG > 140 mg/dl | 3 | 10 |
IFG nadir < 54 mg/dl | 3 | 11 |
IFG nadir ≤ 40 mg/dl | 0 | 4 |
IFG maximal excursion (mg/dl) | 111.7 ± 2.4 | 130.1 ± 18.7 |
Time from IFG peak to nadir (minutes) | 69.7 ± 4.4 | 90.9 ± 6.0 |
Symptoms concurrent with LGE (n) | 1 of 1 | 3 of 5 |
Only autonomic | 0 of 0 | 0 of 0 |
Only neuroglycopenic | 0 of 0 | 1 of 2 |
Autonomic and neuroglycopenic | 1 of 1 | 2 of 3 |
FGM evaluation analysis | ||
Duration (days) | 11.87 | 11.88 |
Valid readings (N) | 1,099 | 1,129 |
Data capture rate (%) | 97.44 | 99.55 |
IFG (mg/dl) | 90 (79–111) | 88 (78–114) |
Time IFG > 140 mg/dl (%) | 7.23 | 11.99 |
Time IFG 70–140 mg/dl (%) | 89.81 | 77.48 |
Time IFG < 70 mg/dl (%) | 2.95 | 10.53 |
Time IFG < 54 mg/dl (%) | 0.00 | 2.92 |
MAG change (mmol/l × h−1) | 2.7 | 3.0 |
LBGIFGMGT | 2.3 | 5.2 |
HBGIFGMGT | 2.4 | 3.3 |
ADRRFGMGT | 50.2 | 67.1 |
CONGA1 | 2.4 | 2.9 |
MODD | 1.2 | 1.6 |
